News and Trends 4 Apr 2023
BioNTech adds antibody-drug conjugates to cancer portfolio with potential $1.5B partnership deal
BioNTech SE and Duality Biologics (Suzhou) Co. Ltd. have entered into exclusive license and collaboration agreements for two antibody-drug conjugate…